Revelation Biosciences Ownership 2024 | Who Owns Revelation Biosciences Now?

Overview RevenueFinancials Chart

Institutional Ownership

101.40%

Insider Ownership

0.32%

Retail Ownership

-1.72%

Institutional Holders

10.00

Revelation Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ALTIUM CAPITAL MANAGEMENT LP	100.00%	0.03%	37,198	37,198	100.00%	48,357,000	Mar 31, 2023
WALLEYE CAPITAL LLC	100.00%	0.00%	174,685	174,685	100.00%	227,091,000	Mar 31, 2023
CVI HOLDINGS, LLC	100.00%	0.02%	33,204	33,204	100.00%	43,165,000	Mar 31, 2023
AXA S.A.	100.00%	0.00%	55,971	55,971	100.00%	72,762,000	Mar 31, 2023
HUDSON BAY CAPITAL MANAGEMENT LP	100.00%	0.00%	109,520	109,520	100.00%	142,376,000,000	Mar 31, 2023
ANSON FUNDS MANAGEMENT LP	100.00%	0.05%	213,509	213,509	100.00%	277,562,000	Mar 31, 2023
SABBY MANAGEMENT, LLC	100.00%	0.20%	180,431	180,431	100.00%	234,560,000	Mar 31, 2023
UBS GROUP AG	8.84%	-	1,362	1,362	100.00%	1,771,000	Mar 31, 2023
MORGAN STANLEY	0.80%	-	123	123	100.00%	160,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.02%	-	3	3	100.00%	4,000	Mar 31, 2023
MAYFLOWER FINANCIAL ADVISORS, LLC	-	-	-	-613	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-123	-100.00%	-	Mar 31, 2023
AXA S.A.	-	-	-	-55,971	-100.00%	-	Mar 31, 2023
CWM, LLC	-	-	-	-125	-100.00%	-	Mar 31, 2023
VALEO FINANCIAL ADVISORS, LLC	-	-	-	-286	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-1,126	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-4	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-3,110	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-243	-100.00%	-	Mar 31, 2023
REBALANCE, LLC	-	-	-	-2,453	-100.00%	-	Mar 31, 2023

Revelation Biosciences's largest institutional shareholder is ALTIUM CAPITAL MANAGEMENT LP, holding 100.00% of the company's total share outstanding, currently valued at $48.36M. The top 10 institutional shareholders own together 709.66% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	100.00%	0.20%	180,431	180,431	100.00%	234,560,000	Mar 31, 2023
ANSON FUNDS MANAGEMENT LP	100.00%	0.05%	213,509	213,509	100.00%	277,562,000	Mar 31, 2023
ALTIUM CAPITAL MANAGEMENT LP	100.00%	0.03%	37,198	37,198	100.00%	48,357,000	Mar 31, 2023
CVI HOLDINGS, LLC	100.00%	0.02%	33,204	33,204	100.00%	43,165,000	Mar 31, 2023
WALLEYE CAPITAL LLC	100.00%	0.00%	174,685	174,685	100.00%	227,091,000	Mar 31, 2023
HUDSON BAY CAPITAL MANAGEMENT LP	100.00%	0.00%	109,520	109,520	100.00%	142,376,000,000	Mar 31, 2023
AXA S.A.	100.00%	0.00%	55,971	55,971	100.00%	72,762,000	Mar 31, 2023
UBS GROUP AG	8.84%	-	1,362	1,362	100.00%	1,771,000	Mar 31, 2023
MORGAN STANLEY	0.80%	-	123	123	100.00%	160,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.02%	-	3	3	100.00%	4,000	Mar 31, 2023
MAYFLOWER FINANCIAL ADVISORS, LLC	-	-	-	-613	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-123	-100.00%	-	Mar 31, 2023
AXA S.A.	-	-	-	-55,971	-100.00%	-	Mar 31, 2023
CWM, LLC	-	-	-	-125	-100.00%	-	Mar 31, 2023
VALEO FINANCIAL ADVISORS, LLC	-	-	-	-286	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-1,126	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-4	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-3,110	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-243	-100.00%	-	Mar 31, 2023
REBALANCE, LLC	-	-	-	-2,453	-100.00%	-	Mar 31, 2023

The largest Revelation Biosciences shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 180.43K shares of Revelation Biosciences (REVB), representing 0.20% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ANSON FUNDS MANAGEMENT LP	100.00%	0.05%	213,509	213,509	100.00%	277,562,000	Mar 31, 2023
SABBY MANAGEMENT, LLC	100.00%	0.20%	180,431	180,431	100.00%	234,560,000	Mar 31, 2023
WALLEYE CAPITAL LLC	100.00%	0.00%	174,685	174,685	100.00%	227,091,000	Mar 31, 2023
HUDSON BAY CAPITAL MANAGEMENT LP	100.00%	0.00%	109,520	109,520	100.00%	142,376,000,000	Mar 31, 2023
AXA S.A.	100.00%	0.00%	55,971	55,971	100.00%	72,762,000	Mar 31, 2023
ALTIUM CAPITAL MANAGEMENT LP	100.00%	0.03%	37,198	37,198	100.00%	48,357,000	Mar 31, 2023
CVI HOLDINGS, LLC	100.00%	0.02%	33,204	33,204	100.00%	43,165,000	Mar 31, 2023
UBS GROUP AG	8.84%	-	1,362	1,362	100.00%	1,771,000	Mar 31, 2023
MORGAN STANLEY	0.80%	-	123	123	100.00%	160,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.02%	-	3	3	100.00%	4,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-4	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-123	-100.00%	-	Mar 31, 2023
CWM, LLC	-	-	-	-125	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-243	-100.00%	-	Mar 31, 2023
VALEO FINANCIAL ADVISORS, LLC	-	-	-	-286	-100.00%	-	Mar 31, 2023
MAYFLOWER FINANCIAL ADVISORS, LLC	-	-	-	-613	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-1,126	-100.00%	-	Mar 31, 2023
REBALANCE, LLC	-	-	-	-2,453	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-3,110	-100.00%	-	Mar 31, 2023
AXA S.A.	-	-	-	-55,971	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Revelation Biosciences's largest institutional buyer is ANSON FUNDS MANAGEMENT LP. The company purchased 213.51K stocks of REVB, valued at $277.56M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AXA S.A.	-	-	-	-55,971	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-3,110	-100.00%	-	Mar 31, 2023
REBALANCE, LLC	-	-	-	-2,453	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-1,126	-100.00%	-	Mar 31, 2023
MAYFLOWER FINANCIAL ADVISORS, LLC	-	-	-	-613	-100.00%	-	Mar 31, 2023
VALEO FINANCIAL ADVISORS, LLC	-	-	-	-286	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-243	-100.00%	-	Mar 31, 2023
CWM, LLC	-	-	-	-125	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-123	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-4	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.02%	-	3	3	100.00%	4,000	Mar 31, 2023
MORGAN STANLEY	0.80%	-	123	123	100.00%	160,000	Mar 31, 2023
UBS GROUP AG	8.84%	-	1,362	1,362	100.00%	1,771,000	Mar 31, 2023
CVI HOLDINGS, LLC	100.00%	0.02%	33,204	33,204	100.00%	43,165,000	Mar 31, 2023
ALTIUM CAPITAL MANAGEMENT LP	100.00%	0.03%	37,198	37,198	100.00%	48,357,000	Mar 31, 2023
AXA S.A.	100.00%	0.00%	55,971	55,971	100.00%	72,762,000	Mar 31, 2023
HUDSON BAY CAPITAL MANAGEMENT LP	100.00%	0.00%	109,520	109,520	100.00%	142,376,000,000	Mar 31, 2023
WALLEYE CAPITAL LLC	100.00%	0.00%	174,685	174,685	100.00%	227,091,000	Mar 31, 2023
SABBY MANAGEMENT, LLC	100.00%	0.20%	180,431	180,431	100.00%	234,560,000	Mar 31, 2023
ANSON FUNDS MANAGEMENT LP	100.00%	0.05%	213,509	213,509	100.00%	277,562,000	Mar 31, 2023

As of Mar 31 2023, Revelation Biosciences's biggest institutional seller is AXA S.A.. The company sold -55.97K shares of REVB, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ANSON FUNDS MANAGEMENT LP	100.00%	0.05%	213,509	213,509	100.00%	277,562,000	Mar 31, 2023
SABBY MANAGEMENT, LLC	100.00%	0.20%	180,431	180,431	100.00%	234,560,000	Mar 31, 2023
WALLEYE CAPITAL LLC	100.00%	0.00%	174,685	174,685	100.00%	227,091,000	Mar 31, 2023
HUDSON BAY CAPITAL MANAGEMENT LP	100.00%	0.00%	109,520	109,520	100.00%	142,376,000,000	Mar 31, 2023
AXA S.A.	100.00%	0.00%	55,971	55,971	100.00%	72,762,000	Mar 31, 2023
ALTIUM CAPITAL MANAGEMENT LP	100.00%	0.03%	37,198	37,198	100.00%	48,357,000	Mar 31, 2023
CVI HOLDINGS, LLC	100.00%	0.02%	33,204	33,204	100.00%	43,165,000	Mar 31, 2023
UBS GROUP AG	8.84%	-	1,362	1,362	100.00%	1,771,000	Mar 31, 2023
MORGAN STANLEY	0.80%	-	123	123	100.00%	160,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.02%	-	3	3	100.00%	4,000	Mar 31, 2023

Revelation Biosciences's largest new institutional shareholder by number of shares is ANSON FUNDS MANAGEMENT LP, purchased 213.51K shares, valued at $277.56M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AXA S.A.	-	-	-	-55,971	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-3,110	-100.00%	-	Mar 31, 2023
REBALANCE, LLC	-	-	-	-2,453	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-1,126	-100.00%	-	Mar 31, 2023
MAYFLOWER FINANCIAL ADVISORS, LLC	-	-	-	-613	-100.00%	-	Mar 31, 2023
VALEO FINANCIAL ADVISORS, LLC	-	-	-	-286	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-243	-100.00%	-	Mar 31, 2023
CWM, LLC	-	-	-	-125	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-123	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-4	-100.00%	-	Mar 31, 2023

Revelation Biosciences's largest sold out institutional shareholder by shares sold is AXA S.A., sold -55.97K shares, valued at -, as of undefined.

Revelation Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
T. Rowe Price Small-Cap Value Fund, Inc.	0.06%	467,934	-	-	Mar 31, 2024
BRIDGEWAY FUNDS INC	0.05%	121,263	-	-	Mar 28, 2024
NEXPOINT FUNDS I	0.00%	16,989	-	-	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	35,709	-	-	Feb 29, 2024
NEUBERGER BERMAN ALTERNATIVE FUNDS	0.00%	900	-	-	Jan 31, 2024
VANGUARD INDEX FUNDS	0.00%	12,000	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	5,940	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	1,542	-	-	Feb 29, 2024
MASSMUTUAL SELECT FUNDS	0.00%	5,395	-	-	Dec 31, 2023

Revelation Biosciences's largest mutual fund holder by % of total assets is "T. Rowe Price Small-Cap Value Fund, Inc.", owning 467.93K shares, compromising 0.06% of its total assets.

Revelation Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 22	10	-23.08%
30 Sep, 22	13	18.18%
30 Jun, 22	11	-26.67%
31 Mar, 22	15	650.00%
31 Dec, 21	2	-

As of 31 Dec 22, 10 institutions are holding Revelation Biosciences's shares, representing a decrease of -23.08% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 22	2,241,719	-0.35%
30 Sep, 22	2,249,678	-30.10%
30 Jun, 22	3,218,346	6.68%
31 Mar, 22	3,016,821	4593.40%
31 Dec, 21	64,278	-

Revelation Biosciences (REVB) has 2.24M shares outstanding as of 31 Dec 22, down -0.35% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 22	101.40%	0.98%
30 Sep, 22	101.76%	0.48%
30 Jun, 22	145.58%	0.78%
31 Mar, 22	136.46%	1614.18%
31 Dec, 21	2.91%	-

As of 31 Dec 22, Revelation Biosciences is held by 101.40% institutional shareholders, representing a 0.98% growth compared to 30 Sep 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 22	3	-62.50%
30 Sep, 22	8	60.00%
30 Jun, 22	5	-66.67%
31 Mar, 22	15	650.00%
31 Dec, 21	2	-

3 institutional shareholders have increased their position in REVB stock as of 31 Dec 22 compared to 8 in the previous quarter (a -62.50% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 22	1	-
30 Sep, 22	-	-100.00%
30 Jun, 22	1	-
31 Mar, 22	-	-
31 Dec, 21	-	-

1 institutional shareholders have reduced their position in REVB stock as of 31 Dec 22 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 22	10	-23.08%	2,241,719	-0.35%	101.40%	0.98%	3	-62.50%	1	-
30 Sep, 22	13	18.18%	2,249,678	-30.10%	101.76%	0.48%	8	60.00%	-	-100.00%
30 Jun, 22	11	-26.67%	3,218,346	6.68%	145.58%	0.78%	5	-66.67%	1	-
31 Mar, 22	15	650.00%	3,016,821	4593.40%	136.46%	1614.18%	15	650.00%	-	-
31 Dec, 21	2	-	64,278	-	2.91%	-	2	-	-	-

Revelation Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 12, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	27,771	$0.52	$14.44K	-
Oct 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	1,845	$0.65	$1.20K	27,771
Oct 17, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	10,957	$0.66	$7.24K	42,096
Oct 02, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	1,429	$0.69	$986.01	42,096
Sep 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	12,000	$0.75	$9.00K	52,848
Sep 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	9,500	$0.73	$6.93K	43,348
Sep 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	4,000	$0.74	$2.96K	39,348
Apr 19, 2023	TIDMARSH GEORGE F	director	-	P-Purchase	Buy	25,000	$1.16	$29.00K	64,848
Apr 19, 2023	TIDMARSH GEORGE F	director	-	P-Purchase	Buy	26,500	$1.16	$30.74K	39,848
Feb 28, 2022	TIDMARSH GEORGE F	director, 10 percent owner		P-Purchase	Buy	20,000	$1.60	$32.00K	467,156
Feb 10, 2022	TIDMARSH GEORGE F	director, 10 percent owner		P-Purchase	Buy	30,000	$2.55	$76.60K	447,156
Feb 10, 2022	TIDMARSH GEORGE F	director, 10 percent owner		P-Purchase	Buy	1,000	$2.54	$2.54K	417,156

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 19, 2023	TIDMARSH GEORGE F	director	-	P-Purchase	Buy	25,000	$1.16	$29.00K	64,848
Apr 19, 2023	TIDMARSH GEORGE F	director	-	P-Purchase	Buy	26,500	$1.16	$30.74K	39,848
Feb 28, 2022	TIDMARSH GEORGE F	director, 10 percent owner		P-Purchase	Buy	20,000	$1.60	$32.00K	467,156
Feb 10, 2022	TIDMARSH GEORGE F	director, 10 percent owner		P-Purchase	Buy	30,000	$2.55	$76.60K	447,156
Feb 10, 2022	TIDMARSH GEORGE F	director, 10 percent owner		P-Purchase	Buy	1,000	$2.54	$2.54K	417,156

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 12, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	27,771	$0.52	$14.44K	-
Oct 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	1,845	$0.65	$1.20K	27,771
Oct 17, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	10,957	$0.66	$7.24K	42,096
Oct 02, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	1,429	$0.69	$986.01	42,096
Sep 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	12,000	$0.75	$9.00K	52,848
Sep 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	9,500	$0.73	$6.93K	43,348
Sep 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	4,000	$0.74	$2.96K	39,348

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 12, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	27,771	$0.52	$14.44K	-
Oct 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	1,845	$0.65	$1.20K	27,771
Oct 17, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	10,957	$0.66	$7.24K	42,096
Oct 02, 2023	Chawla Lakhmir S	director			Buy	-	-	-	-
Oct 02, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	1,429	$0.69	$986.01	42,096
Sep 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	12,000	$0.75	$9.00K	52,848
Sep 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	9,500	$0.73	$6.93K	43,348
Sep 18, 2023	TIDMARSH GEORGE F	director	-	S-Sale	Sell	4,000	$0.74	$2.96K	39,348
Apr 19, 2023	TIDMARSH GEORGE F	director	-	P-Purchase	Buy	25,000	$1.16	$29.00K	64,848
Apr 19, 2023	TIDMARSH GEORGE F	director	-	P-Purchase	Buy	26,500	$1.16	$30.74K	39,848
Apr 18, 2023	TIDMARSH GEORGE F	director	-	A-Award	Buy	6,356	$1.19	$7.56K	6,356
Apr 18, 2023	ROPER JESS	director	-	A-Award	Buy	6,356	$1.19	$7.56K	6,356
Apr 18, 2023	LaBelle Curt H	director	-	A-Award	Buy	6,356	$1.19	$7.56K	6,356
Apr 18, 2023	CARVER JENNIFER	director	-	A-Award	Buy	6,356	$1.19	$7.56K	6,356
Feb 28, 2023	Zygmont Chester Stanley III	officer	Chief Financial Officer	A-Award	Buy	611	$49.00	$29.94K	-
Feb 28, 2023	Rolke James	director, officer	Chief Executive Officer	A-Award	Buy	2,542	$49.00	$124.56K	-
Feb 14, 2023	AXA IM Prime Impact Master Fund I SCA SICAV-RAIF		-		Buy	-	-	-	-
Feb 28, 2022	TIDMARSH GEORGE F	director, 10 percent owner		P-Purchase	Buy	20,000	$1.60	$32.00K	467,156
Feb 10, 2022	TIDMARSH GEORGE F	director, 10 percent owner		P-Purchase	Buy	30,000	$2.55	$76.60K	447,156
Feb 10, 2022	TIDMARSH GEORGE F	director, 10 percent owner		P-Purchase	Buy	1,000	$2.54	$2.54K	417,156

The last insider sell of Revelation Biosciences's stock was made by TIDMARSH GEORGE F on Dec 12 2023, selling 27,771 shares at $0.52 per share (valued at $14.44K). The last insider buy of REVB was made by TIDMARSH GEORGE F on Apr 19 2023, buying 25,000 shares at $1.16 per share (worth $29.00K).

Revelation Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	-	2	-
Q3 2023	-	4	-
Q2 2023	6	-	-
Q1 2023	2	-	-
Q4 2022	-	-	-
Q1 2022	-	1	-
Q4 2021	-	-	-

0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by Revelation Biosciences's insiders, as of Q4 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	-	2	-
Q3 2023	-	4	-
Q2 2023	2	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-

As of Q4 2023, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Revelation Biosciences's stocks.

Revelation Biosciences Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
BWV	Onconetix, Inc.
KPRX	Kiora Pharmaceuticals, Inc.
PXMD	PaxMedica, Inc. Common Stock
PHIO	Phio Pharmaceuticals Corp.
QNRX	Quoin Pharmaceuticals, Ltd.
RNAZ	TransCode Therapeutics, Inc.
HILS	Tharimmune, Inc.
VRAX	Virax Biolabs Group Limited
CYTO	Altamira Therapeutics Ltd.
SONN	Sonnet BioTherapeutics Holdings, Inc.
ZURA	Zura Bio Limited

REVB Ownership FAQ

Who Owns Revelation Biosciences?

Revelation Biosciences is owned by institutional shareholders (101.40%), insiders (0.32%), and public (-1.72%). The largest institutional shareholder of Revelation Biosciences is ALTIUM CAPITAL MANAGEMENT LP (100.00% of total shares) and the top mutual fund owner is T. Rowe Price Small-Cap Value Fund, Inc. (0.06% of total shares).

Who are the major institutional shareholders of Revelation Biosciences?

Revelation Biosciences's major institutional shareholders are ALTIUM CAPITAL MANAGEMENT LP, WALLEYE CAPITAL LLC, CVI HOLDINGS, LLC, AXA S.A., and HUDSON BAY CAPITAL MANAGEMENT LP. The top five shareholders own together 500.00% of the company's share outstanding.

How many Revelation Biosciences shareholders are there?

As of Dec 2022, there are 10 institutional shareholders of Revelation Biosciences.

What percentage of Revelation Biosciences is owned by ALTIUM CAPITAL MANAGEMENT LP?

ALTIUM CAPITAL MANAGEMENT LP owns 37.2K shares of Revelation Biosciences, representing 100.00% of the company's total shares outstanding, valued at $48.36M (as of Mar 2023).

What percentage of Revelation Biosciences is owned by WALLEYE CAPITAL LLC?

As of Mar 2023, WALLEYE CAPITAL LLC holds 174.68K shares of Revelation Biosciences (REVB), compromising 100.00% of the company, valued at $227.09M.

What percentage of Revelation Biosciences is owned by CVI HOLDINGS, LLC?

CVI HOLDINGS, LLC is the third largest holder of Revelation Biosciences. The company owns 33.2K of the company's shares outstanding (worth $43.16M).